Pixyl develops Pixyl.Neuro, an AI software that analyzes brain MRI images to detect anomalies associated with neuroinflammatory and neurodegenerative disorders. This technology provides radiologists with clinically actionable insights in under five minutes, enhancing diagnostic accuracy and treatment efficiency.
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The interpretation of brain MRI scans for neuroinflammatory and neurodegenerative diseases is often time-consuming and can be subject to inter-reader variability, potentially delaying diagnosis and treatment decisions. Subtle anomalies indicative of disease progression may be missed, and manual volumetric analysis is labor-intensive.
Solution
Pixyl develops Pixyl.Neuro, an AI-powered software designed to augment the analysis of brain MRI images, facilitating the detection of anomalies associated with neuroinflammatory and neurodegenerative disorders. The software employs advanced AI algorithms to rapidly analyze brain MR images, providing radiologists with clinically actionable insights in under five minutes. By automating the quantification of brain region volumes and comparing them against normative data, Pixyl.Neuro aims to improve the detection of neurological disease activity and accelerate MRI reading times. The platform supports the early diagnosis, objective monitoring, and longitudinal follow-up of neurodegenerative and neuroinflammatory disorders.
Target Audience
The primary target audience includes radiologists, neuroradiologists, and neurologists involved in the diagnosis and management of neuroinflammatory and neurodegenerative diseases. It also caters to hospitals and imaging centers seeking to enhance their radiology workflows.
Features
- AI-driven analysis of brain MRI images for rapid detection of anomalies
- Quantification of brain region volumes and comparison to normative data
- Generative AI technology to ensure robust performance in real-world practice
- Support for the diagnosis and monitoring of neuroinflammatory and neurodegenerative disorders such as multiple sclerosis
- Integration into existing radiology workflows via PACS
- FDA 510(k) clearance and CE-mark class IIa certification